{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:36:04Z","timestamp":1787592964149,"version":"build-2736575974"},"reference-count":163,"publisher":"Elsevier","isbn-type":[{"value":"9780323983921","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DK101528-06"],"award-info":[{"award-number":["5R01DK101528-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK034989"],"award-info":[{"award-number":["P30 DK034989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009680","name":"Yale Liver Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acr.2022.02.001","type":"book-chapter","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T16:24:45Z","timestamp":1646929485000},"page":"39-73","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acr.2022.02.001_bb0010","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acr.2022.02.001_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jhbp.71","article-title":"Histological features of precancerous and early cancerous lesions of biliary tract carcinoma","volume":"21","author":"Aishima","year":"2014","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"key":"10.1016\/bs.acr.2022.02.001_bb0025","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s12885-016-2919-4","article-title":"Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: Clinicopathological features and therapeutic potential for cancer stem cell-like properties","volume":"16","author":"Aoki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0030","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: A systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.acr.2022.02.001_bb0035","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: Cholangiocarcinoma: Current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062478","article-title":"Histone acetylation-mediated regulation of the Hippo pathway","volume":"8","author":"Basu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acr.2022.02.001_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fonc.2020.00109","article-title":"The generation and identity of human myeloid-derived suppressor cells","volume":"10","author":"Bergenfelz","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-933565","article-title":"Liver transplantation in primary sclerosing cholangitis","volume":"26","author":"Bj\u00f8ro","year":"2006","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/bs.acr.2022.02.001_bb0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/bs.acr.2022.02.001_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4254\/wjh.v9.i9.455","article-title":"Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness","volume":"9","author":"Brivio","year":"2017","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clinre.2018.04.008","article-title":"Animal models of cholangiocarcinoma: What they teach us about the human disease","volume":"42","author":"Cadamuro","year":"2018","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/13543784.2021.1880564","article-title":"Targeted therapies for extrahepatic cholangiocarcinoma: Preclinical and clinical development and prospects for the clinic","volume":"30","author":"Cadamuro","year":"2021","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/bs.acr.2022.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bbadis.2017.07.028","article-title":"The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma","volume":"1864","author":"Cadamuro","year":"2018","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10.1016\/bs.acr.2022.02.001_bb0110","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.3390\/ijms19123875","article-title":"Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies","volume":"19","author":"Cannito","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.acr.2022.02.001_bb0115","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1111\/febs.15637","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity","volume":"288","author":"Cardoso Alves","year":"2021","journal-title":"The FEBS Journal"},{"key":"10.1016\/bs.acr.2022.02.001_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fgene.2014.00444","article-title":"Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers","volume":"5","author":"Correia da Costa","year":"2014","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/bs.acr.2022.02.001_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.parint.2011.07.011","article-title":"Secreted Opisthorchis viverrini glutathione S-transferase regulates cell proliferation through AKT and ERK pathways in cholangiocarcinoma","volume":"61","author":"Daorueang","year":"2012","journal-title":"Parasitology International"},{"key":"10.1016\/bs.acr.2022.02.001_bb0135","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/bs.acr.2022.02.001_bb0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hep.26147","article-title":"Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma","volume":"57","author":"El Khatib","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/jhep.2002.34435","article-title":"ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions","volume":"36","author":"Endo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/liv.14098","article-title":"The tumour microenvironment and immune milieu of cholangiocarcinoma","volume":"39","author":"Fabris","year":"2019","journal-title":"Liver International"},{"key":"10.1016\/bs.acr.2022.02.001_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008421","article-title":"Opisthorchis felineus infection, risks, and morbidity in rural Western Siberia, Russian Federation","volume":"14","author":"Fedorova","year":"2020","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.acr.2022.02.001_bb0165","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/hep.24588","article-title":"Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells","volume":"54","author":"Fingas","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0170","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)","volume":"24","author":"Fischer","year":"2009","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/bs.acr.2022.02.001_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590941","article-title":"The Crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy","volume":"10","author":"Ge","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0180","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ajpath.2013.11.027","article-title":"HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis","volume":"184","author":"Gradilone","year":"2014","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0195","article-title":"IL-17 mediated inflammation promotes tumor growth and progression in the skin","volume":"7","author":"He","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.acr.2022.02.001_bb0200","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20966","article-title":"Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells","volume":"42","author":"Isomoto","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0205","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2022.02.001_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/gast.2001.20875","article-title":"Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes","volume":"120","author":"Jaiswal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3727\/105221617X15034976037343","article-title":"Increased YAP activation is associated with hepatic cyst epithelial cell proliferation in ARPKD\/CHF","volume":"17","author":"Jiang","year":"2017","journal-title":"Gene Expression"},{"key":"10.1016\/bs.acr.2022.02.001_bb0220","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.21873\/invivo.11307","article-title":"In vivo study of natural killer (NK) cell cytotoxicity against cholangiocarcinoma in a nude mouse model","volume":"32","author":"Jung","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/bs.acr.2022.02.001_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317733367","article-title":"Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA","volume":"39","author":"Junking","year":"2017","journal-title":"Tumour Biology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0235","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/gutjnl-2016-312137","article-title":"Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?","volume":"65","author":"Karlsen","year":"2016","journal-title":"Gut"},{"key":"10.1016\/bs.acr.2022.02.001_bb0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0245","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0250","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3201\/eid1110.050614","article-title":"Emerging foodborne trematodiasis","volume":"11","author":"Keiser","year":"2005","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/bs.acr.2022.02.001_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/bs.acr.2022.02.001_bb0260","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.3748\/wjg.v21.i48.13418","article-title":"Hepatolithiasis and intrahepatic cholangiocarcinoma: A review","volume":"21","author":"Kim","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005614","article-title":"Clonorchis sinensis antigens alter hepatic macrophage polarization in vitro and in vivo","volume":"11","author":"Kim","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.acr.2022.02.001_bb0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bjc.2017.401","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Kitano","year":"2018","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0275","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","article-title":"Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells","volume":"128","author":"Kobayashi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0280","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"Kunzmann","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0285","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/tgh-2020-04","article-title":"Fibrocystic liver disease: Novel concepts and translational perspectives","volume":"6","author":"Lasagni","year":"2021","journal-title":"Translational Gastroenterology and Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0290","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0295","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1172\/JCI34922","article-title":"MicroRNA15a modulates expression of the cell-cycle regulator Cdc 25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease","volume":"118","author":"Lee","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.acr.2022.02.001_bb0300","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.trecan.2021.01.012","article-title":"Liver inflammation and hepatobiliary cancers","volume":"7","author":"Leone","year":"2021","journal-title":"Trends in Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cld.667","article-title":"Pathological patterns of biliary disease","volume":"10","author":"Lewis","year":"2017","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/bs.acr.2022.02.001_bb0310","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1007\/s13277-014-1939-4","article-title":"Obesity and the risk of cholangiocarcinoma: A meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0315","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.acr.2022.02.001_bb0320","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.28382","article-title":"Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis","volume":"63","author":"Locatelli","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhepr.2019.06.003","article-title":"Immunobiology of cholangiocarcinoma","volume":"1","author":"Loeuillard","year":"2019","journal-title":"JHEP Reports"},{"key":"10.1016\/bs.acr.2022.02.001_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2004.08.012","article-title":"Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression","volume":"6","author":"Luo","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acr.2022.02.001_bb0335","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jhbp.126","article-title":"Molecular mechanism of cholangiocarcinoma carcinogenesis","volume":"21","author":"Maemura","year":"2014","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"key":"10.1016\/bs.acr.2022.02.001_bb0340","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbadis.2018.07.025","article-title":"Animal models of cholestasis: An update on inflammatory cholangiopathies","volume":"1865","author":"Mariotti","year":"2019","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10.1016\/bs.acr.2022.02.001_bb0345","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.27992","article-title":"YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors","volume":"62","author":"Marti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0350","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0355","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.gastro.2011.11.036","article-title":"Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease","volume":"142","author":"Masyuk","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0360","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2169\/internalmedicine.53.1410","article-title":"Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma","volume":"53","author":"Matsumoto","year":"2014","journal-title":"Internal Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0365","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1478-3231.1999.tb00006.x","article-title":"Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition","volume":"19","author":"Matsumoto","year":"1999","journal-title":"Liver"},{"key":"10.1016\/bs.acr.2022.02.001_bb0370","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djz103","article-title":"Smoking, alcohol, and biliary tract cancer risk: A pooling project of 26 prospective studies","volume":"111","author":"McGee","year":"2019","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.acr.2022.02.001_bb0375","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nature Communications"},{"key":"10.1016\/bs.acr.2022.02.001_bb0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"Journal of Autoimmunity"},{"issue":"1","key":"10.1016\/bs.acr.2022.02.001_bb0385","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.acr.2022.02.001_bb0390","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1074\/jbc.M607712200","article-title":"The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes","volume":"282","author":"Meng","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2022.02.001_bb0395","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/cells10082034","article-title":"NAFLD-related hepatocarcinoma: The malignant side of metabolic syndrome","volume":"10","author":"Michelotti","year":"2021","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2022.02.001_bb0400","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2013.02.048","article-title":"The relevance of the TGF-\u03b2 paradox to EMT-MET programs","volume":"341","author":"Morrison","year":"2013","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.acr.2022.02.001_bb0410","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nchembio.765","article-title":"Oxysterols are allosteric activators of the oncoprotein smoothened","volume":"8","author":"Nachtergaele","year":"2012","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0415","article-title":"Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy","author":"Nguyen","year":"2021","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.acr.2022.02.001_bb0420","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.parint.2010.09.008","article-title":"Opisthorchis viverrini excretory\/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte","volume":"59","author":"Ninlawan","year":"2010","journal-title":"Parasitology International"},{"key":"10.1016\/bs.acr.2022.02.001_bb0425","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2022.02.001_bb0430","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/ars.2006.8.1033","article-title":"8-nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: Formation, occurrence, and implications in inflammation and carcinogenesis","volume":"8","author":"Ohshima","year":"2006","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/bs.acr.2022.02.001_bb0435","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/ijc.27496","article-title":"Identification of CXCL5\/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts","volume":"131","author":"Okabe","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0440","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.3390\/ijms22136975","article-title":"The role of microbiota in primary sclerosing cholangitis and related biliary malignancies","volume":"22","author":"\u00d6zdirik","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.acr.2022.02.001_bb0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0450","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00262-018-2212-2","article-title":"Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells","volume":"67","author":"Panya","year":"2018","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.acr.2022.02.001_bb0455","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510300522","article-title":"Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line","volume":"30","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0460","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.diii.2015.05.012","article-title":"Imaging of Von Meyenburg complexes","volume":"97","author":"Pech","year":"2016","journal-title":"Diagnostic and Interventional Imaging"},{"key":"10.1016\/bs.acr.2022.02.001_bb0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-\u03b2-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186643","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare","volume":"12","author":"Petrick","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.acr.2022.02.001_bb0475","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","article-title":"The biology of YAP\/TAZ: Hippo signaling and beyond","volume":"94","author":"Piccolo","year":"2014","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.acr.2022.02.001_bb0480","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbadis.2017.07.024","article-title":"Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology","volume":"1864","author":"Pinto","year":"2018","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10.1016\/bs.acr.2022.02.001_bb0485","doi-asserted-by":"crossref","first-page":"512","DOI":"10.21037\/atm.2016.12.43","article-title":"The \"gut microbiota\" hypothesis in primary sclerosing cholangitis","volume":"4","author":"Pontecorvi","year":"2016","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0490","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5009\/gnl17102","article-title":"Liver fluke-associated biliary tract cancer","volume":"12","author":"Prueksapanich","year":"2018","journal-title":"Gut and Liver"},{"key":"10.1016\/bs.acr.2022.02.001_bb0495","article-title":"The LIN28B\/TGF-\u03b2\/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma","author":"Puthdee","year":"2021","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2022.02.001_bb0500","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(15)60313-0","article-title":"Clonorchiasis","volume":"387","author":"Qian","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/bs.acr.2022.02.001_bb0505","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0510","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s11605-013-2149-x","article-title":"Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma","volume":"17","author":"Reddy","year":"2013","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/bs.acr.2022.02.001_bb0515","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2019.03.007","article-title":"The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine","volume":"100","author":"Rimassa","year":"2019","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/bs.acr.2022.02.001_bb0520","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0525","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1074\/jbc.M115.698472","article-title":"A Hippo and fibroblast growth factor receptor autocrine pathway in cholangiocarcinoma","volume":"291","author":"Rizvi","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2022.02.001_bb0530","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0535","doi-asserted-by":"crossref","first-page":"F890","DOI":"10.1152\/ajprenal.00341.2007","article-title":"Mechanoregulation of intracellular Ca2+ in human autosomal recessive polycystic kidney disease cyst-lining renal epithelial cells","volume":"294","author":"Rohatgi","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0540","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2022.02.001_bb0545","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/bs.acr.2022.02.001_bb0550","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/17474124.2016.1133291","article-title":"New concept: Cellular senescence in pathophysiology of cholangiocarcinoma","volume":"10","author":"Sasaki","year":"2016","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0555","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC\u2014Mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0560","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.acr.2022.02.001_bb0565","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3904\/kjim.2018.062","article-title":"Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma","volume":"35","author":"Seo","year":"2020","journal-title":"The Korean Journal of Internal Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0570","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1542-3565(03)00133-2","article-title":"Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis","volume":"1","author":"Shoda","year":"2003","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0575","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0580","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14728222.2021.2013801","article-title":"Molecular characterization of extrahepatic cholangiocarcinoma: Perihilar and distal tumors display divergent genomic and transcriptomic profiles","volume":"25","author":"Simbolo","year":"2021","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/bs.acr.2022.02.001_bb0585","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20537","article-title":"Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy","volume":"41","author":"Sirica","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0590","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrgastro.2011.222","article-title":"The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma","volume":"9","author":"Sirica","year":"2011","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0595","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.30289","article-title":"Intrahepatic cholangiocarcinoma: Continuing challenges and translational advances","volume":"69","author":"Sirica","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0600","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2020.10.005","article-title":"Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression","volume":"149","author":"Sirica","year":"2021","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2022.02.001_bb0605","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcb.26246","article-title":"Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation","volume":"119","author":"Smoot","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.acr.2022.02.001_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000611","article-title":"A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells","volume":"5","author":"Smout","year":"2009","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.acr.2022.02.001_bb0615","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pep.2011.06.018","article-title":"Expression, refolding and purification of Ov-GRN-1, a granulin-like growth factor from the carcinogenic liver fluke, that causes proliferation of mammalian host cells","volume":"79","author":"Smout","year":"2011","journal-title":"Protein Expression and Purification"},{"key":"10.1016\/bs.acr.2022.02.001_bb0620","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirl\u00ec","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0625","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0065-308X(10)72011-X","article-title":"Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control","volume":"72","author":"Sripa","year":"2010","journal-title":"Advances in Parasitology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0630","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2011.09.022","article-title":"Development of the bile ducts: essentials for the clinical hepatologist","volume":"56","author":"Strazzabosco","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb821","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00535-019-01563-z","article-title":"YAP and the Hippo pathway in cholangiocarcinoma","volume":"54","author":"Sugihara","year":"2019","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0635","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajpath.2019.05.014","article-title":"The expression of Yes-associated protein (YAP) maintains putative cancer stemness and is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"189","author":"Sugiura","year":"2019","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0640","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/2211-5463.12388","article-title":"Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines\u2014A new strategy for therapy","volume":"8","author":"Suksawat","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/bs.acr.2022.02.001_bb0645","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.parint.2016.04.008","article-title":"Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance","volume":"66","author":"Suksawat","year":"2017","journal-title":"Parasitology International"},{"key":"10.1016\/bs.acr.2022.02.001_bb0650","doi-asserted-by":"crossref","first-page":"e 8458","DOI":"10.7717\/peerj.8458","article-title":"CD86+\/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma","volume":"8","author":"Sun","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/bs.acr.2022.02.001_bb0655","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parint.2011.06.018","article-title":"Molecular expression and enzymatic characterization of thioredoxin from the carcinogenic human liver fluke Opisthorchis viverrini","volume":"61","author":"Suttiprapa","year":"2012","journal-title":"Parasitology International"},{"key":"10.1016\/bs.acr.2022.02.001_bb0660","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/jhep.2001.20676","article-title":"Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line","volume":"33","author":"Tadlock","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0665","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/713859","article-title":"Hmgb1-IL-23-IL-17-IL-6-Stat3 axis promotes tumor growth in murine models of melanoma","volume":"2013","author":"Tang","year":"2013","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/bs.acr.2022.02.001_bb0670","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jhbp.125","article-title":"Tumor necrosis factor-\u03b1 modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression","volume":"21","author":"Techasen","year":"2014","journal-title":"Journal of Hepato-Biliary-Pancreatic Sciences"},{"key":"10.1016\/bs.acr.2022.02.001_bb0675","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: A comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/bs.acr.2022.02.001_bb0680","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhep.2019.02.024","article-title":"Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF- production of biliary epithelium","volume":"71","author":"Tsunoda","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0685","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0690","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00436-020-06640-4","article-title":"Oxysterols of helminth parasites and pathogenesis of foodborne hepatic trematodiasis caused by Opisthorchis and Fasciola species","volume":"119","author":"Vale","year":"2020","journal-title":"Parasitology Research"},{"key":"10.1016\/bs.acr.2022.02.001_bb0695","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOG.0000000000000609","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma","volume":"36","author":"Vaquero","year":"2020","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0700","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00247-008-1070-z","article-title":"Fibropolycystic liver disease in children","volume":"39","author":"Veigel","year":"2009","journal-title":"Pediatric Radiology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0705","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","article-title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2022.02.001_bb0710","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3748\/wjg.v22.i10.3038","article-title":"Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis","volume":"22","author":"Wang","year":"2016","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0715","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7150\/thno.63417","article-title":"Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/bs.acr.2022.02.001_bb0720","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1158\/0008-5472.CAN-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"Wehbe","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2022.02.001_bb822","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0725","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/bs.acr.2022.02.001_bb0730","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldv019","article-title":"Primary sclerosing cholangitis: A clinical update","volume":"114","author":"Williamson","year":"2015","journal-title":"British Medical Bulletin"},{"key":"10.1016\/bs.acr.2022.02.001_bb0735","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: A systematic review and meta-analysis","volume":"17","author":"Wongjarupong","year":"2017","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0740","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3892\/or.2014.3123","article-title":"Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro","volume":"31","author":"Wu","year":"2014","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.acr.2022.02.001_bb0745","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.20125","article-title":"Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis","volume":"39","author":"Yoon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0750","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jhep.2004.07.016","article-title":"Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells","volume":"41","author":"Yoon","year":"2004","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0755","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/gast.2002.32410","article-title":"Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000719","article-title":"Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini","volume":"4","author":"Young","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.acr.2022.02.001_bb0765","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.1038\/sj.onc.1208841","article-title":"The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006","volume":"24","author":"Yu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2022.02.001_bb0770","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: A signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0775","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/labinvest.3700236","article-title":"Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta 1 by overexpression of cyclin D1","volume":"85","author":"Zen","year":"2005","journal-title":"Laboratory Investigation"},{"key":"10.1016\/bs.acr.2022.02.001_bb0780","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s001090050221","article-title":"Autosomal recessive polycystic kidney disease","volume":"76","author":"Zerres","year":"1998","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0785","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajpath.2017.12.017","article-title":"Hippo cascade controls lineage commitment of liver tumors in mice and humans","volume":"188","author":"Zhang","year":"2018","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.715852","article-title":"The microbiome in autoimmune liver diseases: Metagenomic and metabolomic changes","volume":"12","author":"Zheng","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.acr.2022.02.001_bb0795","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/carcin\/bgt397","article-title":"CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils","volume":"35","author":"Zhou","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/bs.acr.2022.02.001_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103375","article-title":"Tumor-associated macrophages in cholangiocarcinoma: Complex interplay and potential therapeutic target","volume":"67","author":"Zhou","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/bs.acr.2022.02.001_bb0805","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/bs.acr.2022.02.001_bb0810","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: Evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"}],"container-title":["Advances in Cancer Research","Hepatobiliary Cancers: Translational Advances and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X22000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X22000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T20:16:55Z","timestamp":1753301815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X22000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323983921"],"references-count":163,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2022.02.001","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}